BIotrend Cevre ve EnerjI Yatirimlari AS

As of June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS carries a market capitalization of 9.56B, placing it among publicly traded companies globally. Its enterprise value stands at 15.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

BIotrend Cevre ve EnerjI Yatirimlari AS's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS has 500.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 3.16, and the price-to-book ratio stands at 2.92.

As of June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS trades at an EV/EBITDA multiple of 63.13 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 5.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 15.69B versus a market cap of 9.56B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS maintains a current ratio of 0.32, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 191.59, indicating elevated leverage, while an interest coverage ratio of 0.40 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS posted a negative return on equity (ROE) of -18.11, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -6.28, reflecting losses generated across the asset base. The company generates approximately 3.79M in revenue per employee across its workforce of 797.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 9.74 indicates how many times BIotrend Cevre ve EnerjI Yatirimlari AS sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS recorded 350.68M in income tax expense. The company reported a pretax loss of -320.88M and -671.56M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS's stock has declined approximately 56.50% over the past 52 weeks. The 50-day moving average sits at 14.63, while the 200-day moving average is 17.07.

Over the twelve months ended June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS generated 3.02B in revenue and converted that into -671.56M in net income, yielding earnings per share of -1.34. EBITDA reached 248.49M, while operating income came in at -681.89M.

As of June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS holds 136.05M in cash and equivalents against 6.27B in total debt, resulting in a net debt position of 5.90B. Total book value stands at 3.27B, with working capital of -1.97B providing operational flexibility.

BIotrend Cevre ve EnerjI Yatirimlari AS produced 568.96M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -559.92M in capital expenditures, free cash flow totaled 9.04M - equivalent to 0.02 per share.

Over the twelve months ended June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS posted a gross margin of 0.94, reflecting its pricing power and cost economics. The operating margin of -22.56 and net profit margin of -22.22 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 0.09, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -0.89, meaning BIotrend Cevre ve EnerjI Yatirimlari AS raised more capital through share issuance and new debt than it returned via dividends and buybacks.

BIotrend Cevre ve EnerjI Yatirimlari AS's most recent stock split took place on November 24, 2021 with a 3:10 split ratio.

As of June 30, 2026, BIotrend Cevre ve EnerjI Yatirimlari AS has an Altman Z-Score of 0.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.